|
English
|
正體中文
|
简体中文
|
2809328
|
|
???header.visitor??? :
26885052
???header.onlineuser??? :
378
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"burdaeva o"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2022-06-27T07:01:52Z |
A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: Results of the phase II randomized ABIGAIL study (BO21015)
|
Mok T.; Gorbunova V.; Juhasz E.; Szima B.; Burdaeva O.; Orlov S.; CHONG-JEN YU; Archer V.; Hilton M.; Delmar P.; Pallaud C.; Reck M. |
| 臺大學術典藏 |
2022-06-27T07:01:46Z |
Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer
|
Pallaud C.; Reck M.; Juhasz E.; Szima B.; CHONG-JEN YU; Burdaeva O.; Orlov S.; Hilton M.; Archer V.; Mok T. |
| 國立臺灣大學 |
2012 |
CLINICAL GENOTYPING AND EFFICACY OUTCOMES: EXPLORATORY BIOMARKER DATA FROM THE PHASE II ABIGAIL STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)
|
Pallaud, C.; Reck, M.; Juhasz, E.; Szima, B.; Yu, C.; Burdaeva, O.; Orlov, S.; Scherer, S. J.; Archer, V.; Mok, T. S. K. |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
